
Results
15
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
15 companies
CORONA Remedies
Market Cap: ₹91.8b
A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.
CORONA
₹1,500.50
7D
4.9%
1Y
n/a
Lupin
Market Cap: ₹994.1b
Operates as a pharmaceutical company in India, the United States, and internationally.
500257
₹2,176.25
7D
-0.2%
1Y
3.1%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹397.9b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,348.70
7D
-1.1%
1Y
13.9%
Torrent Pharmaceuticals
Market Cap: ₹1.4t
Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.
500420
₹4,018.75
7D
1.4%
1Y
26.5%
Jagsonpal Pharmaceuticals
Market Cap: ₹11.8b
Engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally.
JAGSNPHARM
₹176.33
7D
-3.5%
1Y
-19.0%
Welcure Drugs and Pharmaceuticals
Market Cap: ₹482.0m
Engages in trading of medical products in India.
524661
₹0.39
7D
-7.1%
1Y
-56.0%
RPG Life Sciences
Market Cap: ₹38.2b
An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.
RPGLIFE
₹2,307.20
7D
-1.5%
1Y
10.8%
AstraZeneca Pharma India
Market Cap: ₹206.3b
A biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.
506820
₹8,251.95
7D
-0.9%
1Y
19.4%
Rubicon Research
Market Cap: ₹111.3b
Operates as a specialty pharmaceutical company in India, the United States, and internationally.
RUBICON
₹675.65
7D
3.9%
1Y
n/a
Blue Jet Healthcare
Market Cap: ₹83.9b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹483.75
7D
-3.3%
1Y
-18.8%
Astal Laboratories
Market Cap: ₹924.4m
Manufactures and sells pharmaceutical intermediates and bulk drugs in India.
512600
₹85.83
7D
5.1%
1Y
21.7%
Fabtech Technologies
Market Cap: ₹8.4b
Operates as a biopharma engineering company that provides aseptic manufacturing facilities internationally.
FABTECH
₹189.60
7D
-0.5%
1Y
n/a
Abbott India
Market Cap: ₹590.2b
Operates as a pharmaceutical company in India.
500488
₹27,776.95
7D
-0.9%
1Y
-0.6%
Nirman Agri Genetics
Market Cap: ₹428.9m
Operates as an agri-input company in India.
NIRMAN
₹53.55
7D
-10.5%
1Y
-85.4%
Curis Lifesciences
Market Cap: ₹997.6m
Operates as a pharmaceutical manufacturer, specializing in manufacturing of a wide range of pharmaceutical products, such as tablets, capsules, external preparations, oral liquid, and sterile ophthalmic ointments in India.
CURIS
₹123.40
7D
-4.9%
1Y
n/a